C-Path

Tucson, United States Founded: 2005 • Age: 21 yrs
Developer of clinical trial tools and data platforms for accelerating drug development

About C-Path

C-Path is a Government & Social Sector company based in Tucson (United States) founded in 2005. Developer of clinical trial tools and data platforms for accelerating drug development. Its website c-path.org draws about 14 thousand monthly visits. Its focus areas include Nonprofits and Foundations. Its legal entity is Critical Path Institute.

Company details

Founded in 2005 and based in Tucson, United States, C-Path operates in the biotechnology sector. Quantitative clinical trial enrichment tools are provided to optimize trial designs for various diseases, aiding participant identification and efficiency. Disease-specific databases are maintained, aggregating de-identified patient data for research and regulatory support. Collaboration is facilitated among researchers, regulators, and pharmaceutical firms to advance therapy development.

Key Metrics
  • Latest Funding Round
    $682.32K (USD), Grant

    Apr 2015

  • Investors

Apps and channels of C-Path

its YouTube channel Critical Path Institute has 758 subscribers and 30 videos.

Critical Path Institute
YouTube 758 subscribers 30 videos Science & Technology
Open channel

Videos from C-Path

The most watched videos on C-Path's YouTube channel, Critical Path Institute (758 subscribers). Click a video to play it here.

Session Three-Four Panel Discussion: C-Peptide as Biomarker in Trials of T1D
102 views
The Critical Path Institute Podcast: eCOA Conversations on Digital Health Technologies
97 views
The Critical Path Institute Podcast: Connecting the Dots in Quantitative Medicine
64 views
RDCA-DAP Demonstration
59 views

More on Critical Path Institute.

Funding Insights of C-Path

  • Total Rounds 6
  • Last Round Grant β€” $682,322
  • First Round $682,322

    (Jul 2007)

  • Investors Count 1

All 6 funding rounds of C-Path with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2015$682,322Grant––
Aug 2010$2.97MGrant––
Sep 2009$9.78MGrant––
Sep 2009$525,000Grant––
Sep 2008$2.97MGrant––
Jul 2007$682,322Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in C-Path

C-Path has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for C-Path

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of C-Path

58 people are tracked at C-Path (33 in leadership, 25 in team).

NameRoleGroup
Yashmin Karten
Scientific DirectorLeadership
Diane Stephenson
Acting Executive Director, Critical Path For Alzheimer's DiseaseLeadership
Karen Stamm
Associate DirectorLeadership
Collin Hovinga
Vice President Of Rare And Orphan DiseasesLeadership
Maaike Everts
Executive DirectorLeadership
Daniel M. Jorgensen
Chief Executive Officer (CEO)Leadership
Rick Liwski
Chief Technology OfficerLeadership
Ramona Walls
Data Collaboration Center DirectorLeadership
Laura Song
Associate Director, DCCLeadership
Scott Cnockaert
Director Of Information TechnologyLeadership
Kristen Swingle
President And Chief Operating OfficerLeadership
Steven Broadbent
Chief Operating OfficerLeadership
Vicki Theurer Crider
Associate Director For Operations, DCCLeadership
Kimberly Ward Barowicz
Associate Director, Strategic Partnerships - Office Of DevelopmentLeadership
Klaus Romero
Chief Science OfficerLeadership
Cheryl Coon
Vice President, Clinical Outcome Assessment ProgramLeadership
Shu Chin
VP Of MIDD & Quantitative Medicine, Office Of ScienceLeadership
Luke Kosinski
Scientific Director Of Quantitative MedicineLeadership
Graham Marsh
Scientific DirectorLeadership
Heidi Grabenstatter
Scientific Director, Rdca-dapLeadership

38 more people are available in the full profile.

Premium access

Complete people profiles for C-Path

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of C-Path

3 dated milestones of C-Path across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded C-Path is founded.
  2. Funding First funding round of $682K.
  3. Funding Latest funding round, Grant, of $682K.

Web traffic of C-Path

The website of C-Path (c-path.org) receives about 13.5K visits a month.

  • Monthly visits
    13.5K

    ▲ 14.4% vs previous month

Similar websites

Websites whose visitors overlap most with C-Path. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
parkinsonsresource.org
parkinsonsresource.org
100%
#1,819,246–
parkinsonsnewstoday.com
parkinsonsnewstoday.com
88%
#376,359–
parkinsonvoiceproject.org
parkinsonvoiceproject.org
87%
#477,203–
reaganudall.org
reaganudall.org
85%
#2,760,043–
fda.gov
84%
#7,606View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for C-Path

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Foundations

3 companies that operate in the same segment as C-Path (Foundations) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Humanitarian services are provided by UNICEF in developing countries.
1946United States
Research institute for improving the human condition by turning knowledge into practice
1958United StatesUSD 7.84 M92
Poverty eradication efforts are coordinated by Global Citizen foundation.
2008New York, New York, United StatesUSD 35 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about C-Path

C-Path was founded in 2005 and raised its 1st funding round 2 years after it was founded.

C-Path is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.

Founded in 2005 and based in Tucson, United States, C-Path operates in the biotechnology sector. Quantitative clinical trial enrichment tools are provided to optimize trial designs for various diseases, aiding participant identification and efficiency. Disease-specific databases are maintained, aggregating de-identified patient data for research and regulatory support. Collaboration is facilitated among researchers, regulators, and pharmaceutical firms to advance therapy development.

C-Path has 1 investor. Key investors include HHS.

C-Path operates through Critical Path Institute.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available